Contraindicated drug–drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care setting in the United States

Autor: Eljaaly, K., Alshehri, S., Bhattacharjee, S., Al-Tawfiq, J.A., Patanwala, A.E.

Publikováno v: In Clinical Microbiology and Infection May 2019 25(5):620-622

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Autor: Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., Bentum-Puijk, W. van, Berry, L.R., Bhimani, Z., Bonten, M.J.M., Bradbury, C.A., Brunkhorst, F.M., Buzgau, A., Cheng, A.C., Detry, M.A., Duffy, E.J., Estcourt, L.J., Fitzgerald, M., Goossens, H., Haniffa, R., Higgins, A.M., Hills, T.E., Horvat, C.M., Lamontagne, F., Lawler, P.R., Leavis, H.L., Linstrum, K.M., Litton, E., Lorenzi, E., Marshall, J.C., Mayr, F.B., McAuley, D.F., McGlothlin, A., McGuinness, S.P., McVerry, B.J., Montgomery, S.K., Morpeth, S.C., Murthy, S., Orr, K., Parke, R.L., Parker, J.C., Patanwala, A.E., Pettilä, V., Rademaker, E., Santos, M.S., Saunders, C.T., Seymour, C.W., Shankar-Hari, M., Sligl, W.I., Turgeon, A.F., Turner, A.M., Veerdonk, F.L. van de, Zarychanski, R., Green, C., Lewis, R.J., Angus, D.C., McArthur, C.J., Berry, S., Schouten, J.A., Pickkers, P., Webb, S.A., Derde, L.P.G.

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 384 (16), pp.1491-1502. ⟨10.1056/NEJMoa2100433⟩
McAuley, D & Writing Committee, REMAP-CAP 2021, ' Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2100433
2021, ' Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 ', New England Journal of Medicine, vol. 384, no. 16, pp. 1491-1502 . https://doi.org/10.1056/NEJMoa2100433
The New England Journal of Medicine, 384, 16, pp. 1491-1502
The New England Journal of Medicine, 384, 1491-1502
NEW ENGLAND JOURNAL OF MEDICINE
REMAP-CAP Investigators, Felton, T & Dark, P 2021, ' Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 ', The New England Journal of Medicine, vol. 384, no. 16, pp. 1491-1502 . https://doi.org/10.1056/NEJMoa2100433
The New England Journal of Medicine

BACKGROUNDThe efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.METHODSWe evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a842cc61a154327cc1bed7cc2b37f04
https://pubmed.ncbi.nlm.nih.gov/34920865

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.